Pregled bibliografske jedinice broj: 305041
Genetic plasticity and antigenic variations of vaccine and wild-type mumps virus strains
Genetic plasticity and antigenic variations of vaccine and wild-type mumps virus strains // Abstracts of the EMBO workshop RNA viruses : replication, evolution and drug design / Rohayem, Jacques ; Snijder, Eric ; Djinović, Kristina (ur.).
Beč, 2007. str. 27-27 (poster, međunarodna recenzija, sažetak, znanstveni)
CROSBI ID: 305041 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Genetic plasticity and antigenic variations of vaccine and wild-type mumps virus strains
Autori
Ivančić-Jelečki, Jelena ; Forčić, Dubravko ; Šantak, Maja
Vrsta, podvrsta i kategorija rada
Sažeci sa skupova, sažetak, znanstveni
Izvornik
Abstracts of the EMBO workshop RNA viruses : replication, evolution and drug design
/ Rohayem, Jacques ; Snijder, Eric ; Djinović, Kristina - Beč, 2007, 27-27
Skup
EMBO workshop RNA viruses : replication, evolution and drug design
Mjesto i datum
Beč, Austrija, 27.08.2007. - 30.08.2007
Vrsta sudjelovanja
Poster
Vrsta recenzije
Međunarodna recenzija
Ključne riječi
mumps; genome; vaccine
Sažetak
Mumps is an acute infectious disease caused by mumps virus (MuV), an RNA virus belonging to Paramyxoviridae family. The disease is usually mild with fever and swelling of the salivary glands, but more serious complications including meningitis and encephalitis may occur. Because of the high mutation rate of viral RNA-dependent RNA polymerase, RNA viruses show considerable adaptability, genetic plasticity and antigenic variations. This characteristic is the basis for development of live attenuated viral vaccines. It is generally believed that MuV is serologically monotypic (immunity induced by one strain is protective against reinfection by any other strain). Still, cases of reinfection, though rare, have been reported as well as laboratory data demonstrating virus strain specific neutralizing antibodies. Furthermore, occurrences of mumps epidemics in countries with an ongoing vaccination programs raise the questions of vaccine efficiency, especially regarding wild type strains more divergent than the vaccine strain. Major targets for the immune response upon mumps virus infection are hemagglutinin-neuraminidase and nucleocapsid proteins. In this work, the comparisons of known antigenic epitopes between vaccine and wild-type MuV strains will be presented. The usefulness of such approach for the monitoring of MuV evolution, the prediction of vaccine efficacy and vaccine development will be discussed.
Izvorni jezik
Engleski
Znanstvena područja
Biologija, Javno zdravstvo i zdravstvena zaštita
POVEZANOST RADA
Projekti:
0021999
021-0212432-3123 - Molekularna patogeneza virusa mumpsa (Šantak, Maja, MZOS ) ( CroRIS)
Ustanove:
Imunološki zavod d.d.